HRMY

insider transactions

Harmony Biosciences Holdings, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 365d

-24.7K

0 buy · 24.7K sell

Net value · 365d

-$892.0K

$0 in · $892.0K out

Sentiment · 365d

Net selling

0% buying · 100% selling

Open-market trades · 365d

0 buy · 24.7K sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
May 14, 26

Ron M Philip

Director

$0

21.9K sh

Own New
Grant·A
May 14, 26

Juan A. Sabater

Director

$0

21.9K sh

Own New
Grant·A
May 14, 26

Linda M Szyper

Director

$0

21.9K sh

Own New
Grant·A
May 14, 26

Gary Sender

Director

$0

21.9K sh

Own New
Exercise·M
May 1, 26

Kumar Budur

CHIEF MEDICAL OFFICER

$0

18.8K sh

Own +100%
Other·F
May 1, 26

Kumar Budur

CHIEF MEDICAL OFFICER

$282.7K

8.9K sh · $31.83

Own -27%
Exercise·M
May 1, 26

Kumar Budur

CHIEF MEDICAL OFFICER

$0

18.8K sh

Own +132%
Grant·A
Apr 14, 26

Glenn Reicin KEY

CHIEF FINANCIAL OFFICER

$0

164.3K sh

Own New
Exercise·M
Apr 7, 26

Adam H. Zaeske

CHIEF COMMERCIAL OFFICER

$0

7.5K sh

Own New
Other·F
Apr 7, 26

Adam H. Zaeske

CHIEF COMMERCIAL OFFICER

$87.6K

3.2K sh · $27.62

Own -42%
Exercise·M
Apr 7, 26

Adam H. Zaeske

CHIEF COMMERCIAL OFFICER

$0

7.5K sh

Own New
Grant·A
Apr 2, 26

Troy A. Ignelzi

Director

$0

17.7K sh

Own New
Grant·A
Apr 2, 26

Peter Anastasiou

CHIEF OPERATING OFFICER

$0

212.2K sh

Own New
Sell·S
Jan 26, 26

Sandip Kapadia KEY

CHIEF FINANCIAL OFFICER · 10b5-1

$139.2K

3.7K sh · $37.15

Own -13%
Exercise·M
Jan 25, 26

Andrew Serafin

CHIEF STRATEGY OFFICER

$0

2.6K sh

Own +50%
Other·F
Jan 25, 26

Andrew Serafin

CHIEF STRATEGY OFFICER

$41.5K

1.1K sh · $36.82

Own -43%
Exercise·M
Jan 25, 26

Andrew Serafin

CHIEF STRATEGY OFFICER

$0

2.6K sh

Own New
Exercise·M
Jan 25, 26

Sandip Kapadia KEY

CHIEF FINANCIAL OFFICER

$0

4.7K sh

Own +50%
Other·F
Jan 25, 26

Sandip Kapadia KEY

CHIEF FINANCIAL OFFICER

$94.0K

2.6K sh · $36.82

Own -54%
Exercise·M
Jan 25, 26

Sandip Kapadia KEY

CHIEF FINANCIAL OFFICER

$0

4.7K sh

Own New
Exercise·M
Jan 25, 26

Jeffrey M. Dayno KEY

PRESIDENT, CEO

$0

13.0K sh

Own +50%
Other·F
Jan 25, 26

Jeffrey M. Dayno KEY

PRESIDENT, CEO

$208.2K

5.7K sh · $36.82

Own -43%
Exercise·M
Jan 25, 26

Jeffrey M. Dayno KEY

PRESIDENT, CEO

$0

13.0K sh

Own New
Exercise·M
Jan 25, 26

Kumar Budur

CHIEF MEDICAL OFFICER

$0

2.7K sh

Own +50%
Other·F
Jan 25, 26

Kumar Budur

CHIEF MEDICAL OFFICER

$50.5K

1.4K sh · $36.82

Own -52%
Exercise·M
Jan 25, 26

Kumar Budur

CHIEF MEDICAL OFFICER

$0

2.7K sh

Own New
Exercise·M
Jan 24, 26

Andrew Serafin

CHIEF STRATEGY OFFICER

$0

2.5K sh

Own +100%
Other·F
Jan 24, 26

Andrew Serafin

CHIEF STRATEGY OFFICER

$41.1K

1.1K sh · $36.82

Own -45%
Exercise·M
Jan 24, 26

Andrew Serafin

CHIEF STRATEGY OFFICER

$0

2.5K sh

Own New
Exercise·M
Jan 24, 26

Sandip Kapadia KEY

CHIEF FINANCIAL OFFICER

$0

3.8K sh

Own +100%
Other·F
Jan 24, 26

Sandip Kapadia KEY

CHIEF FINANCIAL OFFICER

$82.4K

2.2K sh · $36.82

Own -59%
Exercise·M
Jan 24, 26

Sandip Kapadia KEY

CHIEF FINANCIAL OFFICER

$0

3.8K sh

Own New
Exercise·M
Jan 24, 26

Jeffrey M. Dayno KEY

PRESIDENT, CEO

$0

10.5K sh

Own +100%
Other·F
Jan 24, 26

Jeffrey M. Dayno KEY

PRESIDENT, CEO

$176.2K

4.8K sh · $36.82

Own -46%
Exercise·M
Jan 24, 26

Jeffrey M. Dayno KEY

PRESIDENT, CEO

$0

10.5K sh

Own New
Exercise·M
Jan 24, 26

Kumar Budur

CHIEF MEDICAL OFFICER

$0

2.2K sh

Own +110%
Other·F
Jan 24, 26

Kumar Budur

CHIEF MEDICAL OFFICER

$42.5K

1.2K sh · $36.82

Own -53%
Exercise·M
Jan 24, 26

Kumar Budur

CHIEF MEDICAL OFFICER

$0

2.2K sh

Own New
Grant·A
Jan 22, 26

Adam H. Zaeske

CHIEF COMMERCIAL OFFICER

$0

16.2K sh

Own New
Grant·A
Jan 22, 26

Adam H. Zaeske

CHIEF COMMERCIAL OFFICER

$0

56.9K sh

Own New
Grant·A
Jan 22, 26

Andrew Serafin

CHIEF STRATEGY OFFICER

$0

12.2K sh

Own New
Grant·A
Jan 22, 26

Andrew Serafin

CHIEF STRATEGY OFFICER

$0

42.6K sh

Own New
Grant·A
Jan 22, 26

Sandip Kapadia KEY

CHIEF FINANCIAL OFFICER

$0

12.2K sh

Own New
Grant·A
Jan 22, 26

Sandip Kapadia KEY

CHIEF FINANCIAL OFFICER

$0

42.6K sh

Own New
Grant·A
Jan 22, 26

Jeffrey M. Dayno KEY

PRESIDENT, CEO

$0

52.9K sh

Own New
Grant·A
Jan 22, 26

Jeffrey M. Dayno KEY

PRESIDENT, CEO

$0

184.6K sh

Own New
Grant·A
Jan 22, 26

Kumar Budur

CHIEF MEDICAL OFFICER

$0

12.2K sh

Own New
Grant·A
Jan 22, 26

Kumar Budur

CHIEF MEDICAL OFFICER

$0

42.6K sh

Own New
Sell·S
Jan 15, 26

Sandip Kapadia KEY

CHIEF FINANCIAL OFFICER · 10b5-1

$752.8K

21.0K sh · $35.92

Own -100%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
May 14, 2026	Ron M Philip	Director	Grant A	21.9K	New	—	$0
May 14, 2026	Juan A. Sabater	Director	Grant A	21.9K	New	—	$0
May 14, 2026	Linda M Szyper	Director	Grant A	21.9K	New	—	$0
May 14, 2026	Gary Sender	Director	Grant A	21.9K	New	—	$0
May 1, 2026	Kumar Budur	CHIEF MEDICAL OFFICER	Exercise M	18.8K	+100%	—	$0
May 1, 2026	Kumar Budur	CHIEF MEDICAL OFFICER	Other F	8.9K	-27%	$31.83	$282.7K
May 1, 2026	Kumar Budur	CHIEF MEDICAL OFFICER	Exercise M	18.8K	+132%	—	$0
Apr 14, 2026	Glenn Reicin KEY	CHIEF FINANCIAL OFFICER	Grant A	164.3K	New	—	$0
Apr 7, 2026	Adam H. Zaeske	CHIEF COMMERCIAL OFFICER	Exercise M	7.5K	New	—	$0
Apr 7, 2026	Adam H. Zaeske	CHIEF COMMERCIAL OFFICER	Other F	3.2K	-42%	$27.62	$87.6K
Apr 7, 2026	Adam H. Zaeske	CHIEF COMMERCIAL OFFICER	Exercise M	7.5K	New	—	$0
Apr 2, 2026	Troy A. Ignelzi	Director	Grant A	17.7K	New	—	$0
Apr 2, 2026	Peter Anastasiou	CHIEF OPERATING OFFICER	Grant A	212.2K	New	—	$0
Jan 26, 2026	Sandip Kapadia KEY 10b5-1	CHIEF FINANCIAL OFFICER	Sell S	3.7K	-13%	$37.15	$139.2K
Jan 25, 2026	Andrew Serafin	CHIEF STRATEGY OFFICER	Exercise M	2.6K	+50%	—	$0
Jan 25, 2026	Andrew Serafin	CHIEF STRATEGY OFFICER	Other F	1.1K	-43%	$36.82	$41.5K
Jan 25, 2026	Andrew Serafin	CHIEF STRATEGY OFFICER	Exercise M	2.6K	New	—	$0
Jan 25, 2026	Sandip Kapadia KEY	CHIEF FINANCIAL OFFICER	Exercise M	4.7K	+50%	—	$0
Jan 25, 2026	Sandip Kapadia KEY	CHIEF FINANCIAL OFFICER	Other F	2.6K	-54%	$36.82	$94.0K
Jan 25, 2026	Sandip Kapadia KEY	CHIEF FINANCIAL OFFICER	Exercise M	4.7K	New	—	$0
Jan 25, 2026	Jeffrey M. Dayno KEY	PRESIDENT, CEO	Exercise M	13.0K	+50%	—	$0
Jan 25, 2026	Jeffrey M. Dayno KEY	PRESIDENT, CEO	Other F	5.7K	-43%	$36.82	$208.2K
Jan 25, 2026	Jeffrey M. Dayno KEY	PRESIDENT, CEO	Exercise M	13.0K	New	—	$0
Jan 25, 2026	Kumar Budur	CHIEF MEDICAL OFFICER	Exercise M	2.7K	+50%	—	$0
Jan 25, 2026	Kumar Budur	CHIEF MEDICAL OFFICER	Other F	1.4K	-52%	$36.82	$50.5K
Jan 25, 2026	Kumar Budur	CHIEF MEDICAL OFFICER	Exercise M	2.7K	New	—	$0
Jan 24, 2026	Andrew Serafin	CHIEF STRATEGY OFFICER	Exercise M	2.5K	+100%	—	$0
Jan 24, 2026	Andrew Serafin	CHIEF STRATEGY OFFICER	Other F	1.1K	-45%	$36.82	$41.1K
Jan 24, 2026	Andrew Serafin	CHIEF STRATEGY OFFICER	Exercise M	2.5K	New	—	$0
Jan 24, 2026	Sandip Kapadia KEY	CHIEF FINANCIAL OFFICER	Exercise M	3.8K	+100%	—	$0
Jan 24, 2026	Sandip Kapadia KEY	CHIEF FINANCIAL OFFICER	Other F	2.2K	-59%	$36.82	$82.4K
Jan 24, 2026	Sandip Kapadia KEY	CHIEF FINANCIAL OFFICER	Exercise M	3.8K	New	—	$0
Jan 24, 2026	Jeffrey M. Dayno KEY	PRESIDENT, CEO	Exercise M	10.5K	+100%	—	$0
Jan 24, 2026	Jeffrey M. Dayno KEY	PRESIDENT, CEO	Other F	4.8K	-46%	$36.82	$176.2K
Jan 24, 2026	Jeffrey M. Dayno KEY	PRESIDENT, CEO	Exercise M	10.5K	New	—	$0
Jan 24, 2026	Kumar Budur	CHIEF MEDICAL OFFICER	Exercise M	2.2K	+110%	—	$0
Jan 24, 2026	Kumar Budur	CHIEF MEDICAL OFFICER	Other F	1.2K	-53%	$36.82	$42.5K
Jan 24, 2026	Kumar Budur	CHIEF MEDICAL OFFICER	Exercise M	2.2K	New	—	$0
Jan 22, 2026	Adam H. Zaeske	CHIEF COMMERCIAL OFFICER	Grant A	16.2K	New	—	$0
Jan 22, 2026	Adam H. Zaeske	CHIEF COMMERCIAL OFFICER	Grant A	56.9K	New	—	$0
Jan 22, 2026	Andrew Serafin	CHIEF STRATEGY OFFICER	Grant A	12.2K	New	—	$0
Jan 22, 2026	Andrew Serafin	CHIEF STRATEGY OFFICER	Grant A	42.6K	New	—	$0
Jan 22, 2026	Sandip Kapadia KEY	CHIEF FINANCIAL OFFICER	Grant A	12.2K	New	—	$0
Jan 22, 2026	Sandip Kapadia KEY	CHIEF FINANCIAL OFFICER	Grant A	42.6K	New	—	$0
Jan 22, 2026	Jeffrey M. Dayno KEY	PRESIDENT, CEO	Grant A	52.9K	New	—	$0
Jan 22, 2026	Jeffrey M. Dayno KEY	PRESIDENT, CEO	Grant A	184.6K	New	—	$0
Jan 22, 2026	Kumar Budur	CHIEF MEDICAL OFFICER	Grant A	12.2K	New	—	$0
Jan 22, 2026	Kumar Budur	CHIEF MEDICAL OFFICER	Grant A	42.6K	New	—	$0
Jan 15, 2026	Sandip Kapadia KEY 10b5-1	CHIEF FINANCIAL OFFICER	Sell S	21.0K	-100%	$35.92	$752.8K

About HRMY insider trading

This page tracks insider transactions for Harmony Biosciences Holdings, Inc. (HRMY) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.